Research

Hormonal

Use of GLP-1 receptor agonists (GLP-1 RAs) is associated with an increased incidence of diabetic retinopathy (DR) with a hazard ratio (HR) of 1.07 (95% CI, 1.03-1.11).

Clinicians should be aware of the increased risk of DR when prescribing GLP-1 RAs to patients with T2D.

StrongSupportsmedium confidence
Use of GLP-1 RAs was associated with an increased incidence of DR (hazard ratio [HR], 1.07; 95% CI, 1.03-1.11).
David J. Ramsey et al. · JAMA Network Open · 2025

Why this rating

Based on a large retrospective cohort study design.

Source

GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes

David J. Ramsey et al. · JAMA Network Open · 2025

DOI 10.1001/jamanetworkopen.2025.26321

cohort · n=185066Cited 41×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →